Klebsiella Pneumoniae Infection Clinical Trial
Official title:
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
Klebsiella pneumoniae is one of the most common pathogens causing nosocomial infection. Recently, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics, and the rationality of the current therapy for the CRKP infection. Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, and the rationality of the current therapy for the CRKP infection.
All the patients with culture positive of Klebsiella pneumoniae were screened and reported to the the clinical doctors and confirmed by them. And the clinical characteristics of the patiens, such as baseline data, outcomes etc, were recorded. Finially, to find the prevalence, risk factors, characteristics, and the rationality of the current therapy for the CRKP infection ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04413305 -
WGS-guided Tracking and Infection Control Measures of CRKP
|
N/A | |
| Recruiting |
NCT03598543 -
Epidemiology of Klebsiella Pneumoniae in China
|
||
| Completed |
NCT04959344 -
Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03891433 -
Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae
|
Phase 4 |